Aerovate Therapeutics, Inc. Quarterly Common Stock, Shares, Outstanding from Q4 2020 to Q2 2024

Taxonomy & unit
us-gaap: shares
Description
Number of shares of common stock outstanding. Common stock represent the ownership interest in a corporation.
Summary
Aerovate Therapeutics, Inc. quarterly Common Stock, Shares, Outstanding history and growth rate from Q4 2020 to Q2 2024.
  • Aerovate Therapeutics, Inc. Common Stock, Shares, Outstanding for the quarter ending June 30, 2024 was 28.9M shares, a 4.54% increase year-over-year.
Common Stock, Shares, Outstanding, Quarterly (shares)
Common Stock, Shares, Outstanding, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Date Report Filed
Q2 2024 28.9M +1.25M +4.54% Jun 30, 2024 10-Q 2024-08-12
Q1 2024 27.9M +3.08M +12.4% Mar 31, 2024 10-Q 2024-05-13
Q4 2023 27.8M +3.04M +12.3% Dec 31, 2023 10-Q 2024-08-12
Q3 2023 27.7M +3.15M +12.8% Sep 30, 2023 10-Q 2023-11-13
Q2 2023 27.6M +3.18M +13% Jun 30, 2023 10-Q 2023-08-14
Q1 2023 24.8M +407K +1.67% Mar 31, 2023 10-Q 2023-05-15
Q4 2022 24.7M +313K +1.28% Dec 31, 2022 10-K 2024-03-25
Q3 2022 24.5M +96K +0.39% Sep 30, 2022 10-Q 2022-11-14
Q2 2022 24.4M +24.2M +9946% Jun 30, 2022 10-Q 2022-08-15
Q1 2022 24.4M Mar 31, 2022 10-Q 2022-05-16
Q4 2021 24.4M +24.2M +9942% Dec 31, 2021 10-K 2023-03-29
Q3 2021 24.4M Sep 30, 2021 10-Q 2021-11-15
Q2 2021 243K Jun 30, 2021 10-Q 2021-08-16
Q4 2020 243K Dec 31, 2020 10-K 2022-03-30
* An asterisk sign (*) next to the value indicates that the value is likely invalid.